$ATNM ??PATENT?? Actinium Pharmaceuticals received an Issue Notification from the US Patent and Trademark Office on 7/22 indicating that US Patent No. 10,736,975 will issue on 8/11.
Patent is directed to therapeutic compositions comprising radio-labelled monoclonal antibodies ?? https://t.co/tG6bUdiLeI